PATENT CLAIM ANALYSIS

Application Number: 16252158
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["424", "093210"]

Abstract:
Chimeric antigen receptors containing mesothelin antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.

Claim (Index 64):
The method of  claim 59 , wherein the cancer is a hematological cancer.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.55
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15866222', '15767076', '16132064', '15511973', '15934770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8239085126162476
- 35 USC 102 Novelty (BERT): 0.5978582015693631
- Combined Prediction Score: 0.8013034815115593
- Mean Citation Score: 545.1284919999998
- Max Citation Score: 644.8046
- Similarity Product: 429.5271512702823

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test